Overview
Announcements

Ordinary Rebalance | Solactive Global Genomics Immunology and Medical Revolution Index | Effective Date 3rd June 2024

In the ordinary rebalance, the following composition will be implemented effective open 03.06.2024:

10X GENOMICS INC
ABBVIE INC
AGILENT TECHNOLOGIES INC
ALNYLAM PHARMACEUTICALS INC
AMGEN INC
ASTRAZENECA PLC
AXSOME THERAPEUTICS INC
BEAM THERAPEUTICS INC
BECTON DICKINSON AND CO
BIO-TECHNE CORP
BIOGEN INC
BIONTECH SE
BRISTOL-MYERS SQUIBB CO
CRISPR THERAPEUTICS AG
ELI LILLY & CO
EXACT SCIENCES CORP
GENMAB A/S
GENSCRIPT BIOTECH CORP
GILEAD SCIENCES INC
GUARDANT HEALTH INC
IDEAYA BIOSCIENCES INC
ILLUMINA INC
IMMUNOCORE HOLDINGS PLC
INCYTE CORP
INTELLIA THERAPEUTICS INC
IOVANCE BIOTHERAPEUTICS INC
JAZZ PHARMACEUTICALS PLC
JOHNSON & JOHNSON
LEGEND BIOTECH CORP
LONZA GROUP AG
MERCK & CO. INC.
MODERNA INC
NATERA INC
NOVARTIS AG
PACIFIC BIOSCIENCES OF CALIFORNIA INC
PFIZER INC
PTC THERAPEUTICS INC
QIAGEN NV
REGENERON PHARMACEUTICALS
ROCHE HOLDING AG
RXRX.OQ
SAMSUNG BIOLOGICS CO LTD
SANOFI SA
SAREPTA THERAPEUTICS INC
TG THERAPEUTICS INC
THERMO FISHER SCIENTIFIC INC
TWIST BIOSCIENCE CORP
ULTRAGENYX PHARMACEUTICAL INC
VERACYTE INC
VERTEX PHARMACEUTICALS INC